Ortoli Rosenstadt and Olshan Frome Wolosky advised Springview Holdings Ltd on the offering. Springview Holdings Ltd announced the pricing of its initial public offering of 1,500,000...
You must be a Standard 1 Year member to access this content.
Olshan represented 325 Capital, LLC in the transaction. MultiSensor AI Holdings, Inc. (Nasdaq: MSAI) entered into a securities purchase agreement with 325 Capital, LLC. The agreement...
You must be a Standard 1 Year member to access this content.
Rimon P.C. acted as U.S. legal counsel to Australian Oilseeds. Ellenoff Grossman & Schole LLP acted as U.S. legal counsel to EDOC. Olshan Frome Wolosky LLP...
You must be a Standard 1 Year member to access this content.
Olshan Frome Wolosky represented Star Equity Holdings in the offering. Star Equity Holdings, Inc. (Nasdaq: STRR; STRRP) closed its underwritten public offering of 9,500,000 shares of its common...
You must be a Standard 1 Year member to access this content.
Olshan Frome Wolosky represented P10 in the transaction, while Davis Polk advised the representatives of the several underwriters. P10, Inc., a leading private markets solutions provider, announced...
You must be a Standard 1 Year member to access this content.
Olshan Frome Wolosky LLP advised Alzamend Neuro and Ault Global Holding, while Haynes & Boone LLP represented the underwriter in the offering. Alzamend Neuro, Inc. executed...
You must be a Standard 1 Year member to access this content.
Olshan Frome Wolosky LLP advised Anebulo Pharmaceuticals on the deal. Anebulo Pharmaceuticals, Inc. executed its $21 million initial public offering and listing on The Nasdaq Capital Market...
You must be a Standard 1 Year member to access this content.
Olshan Frome Wolosky LLP advised Anebulo Pharmaceuticals on the deal. Anebulo Pharmaceuticals, Inc. executed its $21 million initial public offering and listing on The Nasdaq Capital Market...
You must be a Standard 1 Year member to access this content.
